Cargando…
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture
The tumour microenvironment (TME) forms a major obstacle in effective cancer treatment and for clinical success of immunotherapy. Conventional co-cultures have shed light onto multiple aspects of cancer immunobiology, but they are limited by the lack of physiological complexity. We develop a human o...
Autores principales: | Di Blasio, S., van Wigcheren, G. F., Becker, A., van Duffelen, A., Gorris, M., Verrijp, K., Stefanini, I., Bakker, G. J., Bloemendal, M., Halilovic, A., Vasaturo, A., Bakdash, G., Hato, S. V., de Wilt, J. H. W., Schalkwijk, J., de Vries, I. J. M., Textor, J. C., van den Bogaard, E. H., Tazzari, M., Figdor, C. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265463/ https://www.ncbi.nlm.nih.gov/pubmed/32488012 http://dx.doi.org/10.1038/s41467-020-16583-0 |
Ejemplares similares
-
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome
por: Gorris, Mark A J, et al.
Publicado: (2022) -
Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
por: Vasaturo, Angela, et al.
Publicado: (2013) -
T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
por: Vasaturo, Angela, et al.
Publicado: (2015) -
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022) -
Novel methodologies for host-microbe interactions and microbiome-targeted therapeutics in 3D organotypic skin models
por: Rikken, Gijs, et al.
Publicado: (2023)